Rapid Ebola Test Could Help in Outbreak

NJ Spotlight News | December 10, 2014 | Healthcare

By Michael Hill
Correspondent

Rutgers University’s Dr. David Alland’s latest research has the potential to save thousands of lives.

“That’s why we go in to this business. It’s not for the high salaries,” he said.

It’s a huge challenge — detecting the various strains of Ebola. But Dr. Alland says in a few months, a California company will have a test to detect the Zaire strain of Ebola that has devastated West Africa.

“Our project is to take that test and then make it available to test other viruses that look like Ebola and as well as malaria,” he said. “This is a test that looks for the presence of the virus and so it can be done every day and in some cases it probably would be done a few days in a row until Ebola was ruled out.”

Dr. Alland’s research and results would take the guess work out of whether to quarantine those suspected of being infected — no waiting 21 days for symptoms to appear.

“The ultimate goal is to have one test that can detect what’s wrong with someone that presents with symptoms that are like Ebola to triage them for quarantine for appropriate therapy if they have Ebola and to triage them for quarantine if they don’t have Ebola and for other appropriate therapy,” he said.

Dr. Alland calls the project very complicated, but it would allow him to build on the success he’s had developing a test to diagnose tuberculosis thanks to a multi-million dollar grant from the National Institutes of Health.

The FDA just approved his TB tests for the U.S. and they’re already widely used in places where Ebola is prevalent. It means the same cartridges, technology and portable “gene expert” devices that diagnose TB can be used for Ebola with results in 30 minutes.

“So the advantage of our test is just adding a new cartridge to an existing platform with a large installed base, a supply chain that’s already established and with people that are trained how to use it,” Dr. Alland said.

At the height of the Ebola crisis a few weeks ago, Dr. Alland called the NIH seeking a supplemental grant — more money — so he and his team could come up with a rapid test to diagnose Ebola.

“We’re very excited about it,” he said.

Elijah Wells founded Operation Amira. He collects and sends supplies to battle Ebola in his parents homeland of Sierra Leone — hard hit by the virus.

He welcomes Dr. Alland’s research.

“Anything that is going to help diagnose the disease in a more rapid manor is going to be effective for people on ground, medical professionals and and individuals who may be infected because they would be getting necessary care quicker,” Wells said.

“We’re talking about speeding up the diagnosis, saving resources and hopefully saving lives,” Dr. Alland said.

Dr. Alland plans to have his rapid Ebola diagnosis test ready to go in 15 months.